As Bob Saget is remembered by his friends and co-stars, one memory that stands out is his commitment to finding a cure for scleroderma, a rare disease for which Saget was the most high-profile ...
Researchers conducted a retrospective cohort study of 114 patients (68% female; median age at onset, 8.3 years; 92% White) with juvenile localized scleroderma from the National Registry for Childhood ...
What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...
Patients who underwent autologous stem cell transplantation (ASCT) for diffuse cutaneous systemic sclerosis (dcSSc), also known as scleroderma, did no better than others receiving conventional ...
(MENAFN- GlobeNewsWire - Nasdaq) Growing Burden of Autoimmune Disorders, Expanding Biologic Pipeline, and Increasing Orphan Drug Support Accelerate Market Expansion. Austin, United States, March 19, ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and ...
Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.
NEW HAVEN, Conn. (WTNH) — June is Scleroderma Awareness Month, which draws attention to the autoimmune disease that leads to chronic hardening and tightening of connective tissues. Dr. Monique ...
NEW HAVEN, Conn. (WTNH) — In today’s Health headlines, June is National Scleroderma Awareness Month. New research being conducted at Yale seeks to improve risk prediction. And, using AI to track the ...
Medically reviewed by Stella Bard, MD Key Takeaways Morning hand stiffness can be caused by conditions like osteoarthritis, rheumatoid arthritis, or carpal tunnel syndrome. Home remedies like gentle ...
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, described a first-of-its-kind validated tool to screen for systemic ...